1. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study
   D. Pastuszak-Lewandoska et al, 2016, Med Oncol CrossRef
2. The roles of microRNAs related with progression and metastasis in human cancers
   Hai-Ting Liu et al, 2016, Tumor Biol. CrossRef
3. Orthotopic non-metastatic and metastatic oral cancer mouse models
   Manish V. Bais et al, 2015, Oral Oncology CrossRef
4. Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT
   Wenfeng Li et al, 2015, Tumor Biol. CrossRef
5. WITHDRAWN: Decreased membrane-type 1 matrix metalloproteinase in gastric cancer suppressed cell migration and invasion via regulating matrix metalloproteinases and epithelial–mesenchymal transition
   Li Cheng et al, 2015, Journal of Surgical Research CrossRef
6. Vitamin K2 promotes mesenchymal stem cell differentiation by inhibiting miR-133a expression
   Yuelei Zhang et al, 2017 CrossRef
7. MicroRNAs as possible biomarkers for screening of aortic aneurysms: a systematic review and validation study
   Areti Moushi et al, 2018, Biomarkers CrossRef
8. MicroRNAs in the Regulation of MMPs and Metastasis
   Mohammed Abba et al, 2014, Cancers CrossRef
9. Extracellular matrix functions in lung cancer
   Martin Götte et al, 2018, Matrix Biology CrossRef
10. Micro-RNAs as critical regulators of matrix metalloproteinases in cancer
    Somaye Noruzi et al, 2018, J Cell Biochem CrossRef
11. HDACs Regulate miR-133a Expression in Pressure Overload–Induced Cardiac Fibrosis
    Ludivine Renaud et al, 2015, Circ Heart Fail CrossRef
12. The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis
    Mahsa Javadian et al, 2018, J Cell Physiol CrossRef
13. Elevated Wall Tension Leads to Reduced miR‐133a in the Thoracic Aorta by Exosome Release
    Adam W. Akerman et al, 2019, J Am Heart Assoc CrossRef
14. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer.
    Georgina Gonzalez-Avila et al, 2019, Crit Rev Oncol Hematol CrossRef
15. Inhibition of MMPs and ADAM/ADAMTS
    Charles J. Malemud, 2019, Biochemical Pharmacology CrossRef
16. Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9
    Dong-Mei Wu et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
17. The circRNA circP4HB promotes NSCLC aggressiveness and metastasis by sponging miR-133a-5p
    Tao Wang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
18. Ciliary Neurotrophic Factor Promotes the Migration of Corneal Epithelial Stem/progenitor Cells by Up-regulation of MMPs through the Phosphorylation of Akt
    Jialin Chen et al, 2016, Sci Rep CrossRef
19. The role of microRNAs in lung cancer progression
    Wen-Cheng Zhang et al, 2013, Med Oncol CrossRef
20. Differences in miRNA Expression in Early Stage Lung Adenocarcinomas that Did and Did Not Relapse
    Mick D. Edmonds et al, 2014, PLoS ONE CrossRef
21. MMP-14 overexpression correlates with poor prognosis in non-small cell lung cancer
    Yu-zhou Wang et al, 2014, Tumor Biol. CrossRef
22. MT1-MMP is not a good prognosticator of cancer survival: evidence from 11 studies
    Kun-peng Wu et al, 2014, Tumor Biol. CrossRef
23. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation ofMMP2
    Hong-Yi Kuo et al, 2014, Cell Cycle CrossRef
24. The Oncogenic Response to MiR-335 Is Associated with Cell Surface Expression of Membrane-Type 1 Matrix Metalloproteinase (MT1-MMP) Activity
    Fausto Rojas et al, 2015, PLoS ONE CrossRef
25. null
    Paula Lopez-Serra et al, 2016 CrossRef
26. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase
    Moustafa Sakr et al, 2016, Gene CrossRef
27. Down-regulation of miR-133a as a poor prognosticator in non-small cell lung cancer
    Yuzhou Wang et al, 2016, Gene CrossRef
28. Epigenetic regulation of TGF-β1 signalling in dilative aortopathy of the thoracic ascending aorta
    Amalia Forte et al, 2016 CrossRef
29. lncRNA XIST promotes glioma proliferation and metastasis through miR‑133a/SOX4
    Chixing Luo et al, 2020, Exp Ther Med CrossRef
30. Cryptotanshinone inhibits lung cancer invasion via microRNA‑133a/matrix metalloproteinase 14 regulation
    Huijuan Wang et al, 2019, Oncol Lett CrossRef
31. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway
    Li Xu et al, 2020, BMC Pulm Med CrossRef
32. Membrane-type I matrix metalloproteinase (MT1-MMP), lipid metabolism, and therapeutic implications
    Xiao-Dan Xia et al, 2021 CrossRef
33. Overexpression of the miR-143/145 and reduced expression of the let-7 and miR-126 for early lung cancer diagnosis
    Lubomír Tulinský et al, 2022, J Appl Biomed CrossRef
34. MicroRNAs in Cancer and Cardiovascular Disease
    Mirolyuba Ilieva et al, 2022, Cells CrossRef
35. Cell-free plasma miRNAs analysis for low invasive lung cancer diagnostics
    M. Yu. Konoshenko et al, 2023, Usp. mol. onkol CrossRef
36. New Directions in Diagnostics for Aortic Aneurysms: Biomarkers and Machine Learning
    Kyle C. Alexander et al, 2024, JCM CrossRef
37. A novel PEC-EC dual-mode biosensing platform for dual target detection of miRNA-133a and cTnI
    Hejie Zheng et al, 2024, Chinese Chemical Letters CrossRef
38. miRNAs in the diagnosis and therapy of cardiac and mediastinal tumors: a new dawn for cardio-oncology?
    Francesco Loreni et al, 2024, Future Cardiology CrossRef